financetom
Business
financetom
/
Business
/
Kits Eyecare Chief Marketing Officer Resigns
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kits Eyecare Chief Marketing Officer Resigns
Oct 16, 2025 4:15 AM

06:49 AM EDT, 10/16/2025 (MT Newswires) -- Kits Eyecare ( KTYCF ) overnight Wednesday announced the resignation of its chief marketing officer, Robert Long, effective Oct. 13, 2025.

A statement noted that, in the interim, marketing responsibilities will be overseen by members of the senior leadership team "to ensure a smooth transition."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US judge says DOL guidance on tipped worker pay survived end of Chevron
US judge says DOL guidance on tipped worker pay survived end of Chevron
Dec 6, 2024
Dec 6 (Reuters) - A U.S. Supreme Court ruling that limited federal agencies' rulemaking powers had no effect on a decades-old regulation involving the proper way to pay workers who receive tips, a federal judge in Colorado has ruled. U.S. District Judge William Martinez in Denver on Thursday said that even though the high court's June ruling in Loper Bright...
Novo Holdings' $16.5 bln Catalent buy wins EU antitrust approval
Novo Holdings' $16.5 bln Catalent buy wins EU antitrust approval
Dec 6, 2024
BRUSSELS, Dec 6 (Reuters) - Novo Holdings on Friday gained unconditional EU antitrust approval for its $16.5 bln acquisition of U.S. contract drug maker Catalent ( CTLT ) after EU regulators said they did not see any competition issues. Novo Holdings, the controlling shareholder of Danish drugmaker Novo Nordisk, which makes the blockbuster weight-loss drug Wegovy, had announced the deal...
Why Genesco Stock Is Trading Higher On Friday
Why Genesco Stock Is Trading Higher On Friday
Dec 6, 2024
Genesco Inc ( GCO ). shares are trading higher on Friday after the company reported third-quarter financial results. It clocked an adjusted earnings per share of 61 cents, beating the street view of 29 cents. Quarterly revenues of $596.328 million (+3%) beat the analyst consensus estimate of $577.93 million. Comparable sales rose 6%, with e-commerce sales up 15% and store...
Novo Holdings' $16.5 billion Catalent buy wins EU antitrust approval
Novo Holdings' $16.5 billion Catalent buy wins EU antitrust approval
Dec 6, 2024
BRUSSELS (Reuters) - Novo Holdings on Friday gained unconditional EU antitrust approval for its $16.5 bln acquisition of U.S. contract drug maker Catalent ( CTLT ) after EU regulators said they did not see any competition issues. Novo Holdings, the controlling shareholder of Danish drugmaker Novo Nordisk, which makes the blockbuster weight-loss drug Wegovy, had announced the deal in February....
Copyright 2023-2026 - www.financetom.com All Rights Reserved